The associations of illness perception with metabolic control (HbA1c) among type 2 diabetes mellitus patients in a district hospital

2017 ◽  
Vol 26 (5) ◽  
pp. 442-449 ◽  
Author(s):  
Soik Fun Lee ◽  
Xin Rou Teh ◽  
Louise Santana Malar ◽  
Su Ling Ong ◽  
Rita Pauline James
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Metabolic Control ◽  
District Hospital ◽  
Illness Perception

scholarly journals Effect of treatment with sitagliptin on somatosensory-evoked potentials and metabolic control in patients with type 2 diabetes mellitus

2014 ◽  
Vol 58 (4) ◽  
pp. 369-376 ◽  
Author(s):  
Joelma Ines Tagliapietra Barros ◽  
Francisco Vagnaldo Fechine ◽  
Renan Magalhães Montenegro Júnior ◽  
Otoni Cardoso do Vale ◽  
Virgínia Oliveira Fernandes ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Evoked Potentials ◽  
Metabolic Control ◽  
Somatosensory Evoked Potentials ◽  
Before And After ◽  
Effect Of Treatment ◽  
Established Role

Objective: To evaluate the effect of sitagliptin on somatosensory-evoked potentials (SEPs) and metabolic control in patients with type 2 diabetes mellitus without clinical diabetic neuropathy. Materials and methods: Interventional, prospective, and open study. Patients with less than six months from the diagnosis were included. Examinations of SEPs and laboratory tests at fasting and after food stimulation were performed before and after three months of treatment with sitagliptin (100 mg/day). Results: There was a reduction in the mean levels of HbA1c (P < 0.0001), fasting glucose (P = 0.001), total cholesterol (P = 0.019), and ALT (P = 0.022). An increase in active GLP-1 was found at the end of the study (P = 0.0025). Several SEPs showed statistically significant differences when analyzed before and after treatment with sitagliptin. Conclusion: The results give a glimpse of the possible use of sitagliptin in the treatment of some neurodegenerative conditions of the peripheral nervous system, in addition to its already established role in glycemic control.

scholarly journals The Correlation Of Self Efficacy With Coping Strategies On Patients Diabetes Mellitus Type 2 Which Use Insulin In Waled Hospital Of Cirebon District

2021 ◽  
Vol 8 (1) ◽  
pp. 7-13
Author(s):  
Anisa ◽  
Nonok Karlina ◽  
Ahmad Syaripudin
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Coping Strategies ◽  
Self Efficacy ◽  
District Hospital ◽  
Rank Test ◽  
P Value ◽  
And Coping

Diabetes mellitus is a disease that has clinical signs and symptoms due to chronic declining function. Type 2 diabetes mellitus always increases every year as much as 9.3% of people. Patients with type 2 diabetes mellitus are required to always be routine control, but patients with diabetes mellitus will experience stress caused by various stressors, to reduce these problems interventions need to provide self-efficacy to patients and coping strategies are also needed so that patients are able to adapt to their stress in order to create coping strategies the good one.The purpose of this study was to determine the relationship of self-efficacy with coping strategies in patients with type 2 diabetes mellitus who use insulin in the Polyclinic of Waled District Hospital Cirebon. This type of research uses descriptive correlational with cross sectional approach. Sampling using purposive sampling technique amounted to 34 respondents. The instrument used was a questionnaire. Analysis of data using rank test speraman.Place of research in Waled District Hospital Cirebon in July 2020. The results showed that most respondents' self-efficacy in the high category (58.8%) and coping strategies were mostly in the good category (61.8%). Spearman rank test results P value <a and r <1 then H0 = rejected means that there is a strong and positive relationship between self-efficacy and coping strategies in patients with type 2 diabetes mellitus in the Polyclinic of Waled District Hospital Cirebon (P value = 0,000: a = 0 .05 r = 0.719). It is expected that nurses should provide more motivation and support to patients with type 2 diabetes mellitus and educate about the importance of coping strategies

Antipsychotic Drugs May Worsen Metabolic Control in Type 2 Diabetes Mellitus

2004 ◽  
Vol 65 (5) ◽  
pp. 674-678 ◽  
Author(s):  
José A. Spoelstra ◽  
Ronald P. Stolk ◽  
Dan Cohen ◽  
Olav H. Klungel ◽  
Joëlle A. Erkens ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Metabolic Control ◽  
Antipsychotic Drugs

scholarly journals Type 2 diabetes mellitus metabolic control correlates with the phenotype of human monocytes and monocyte-derived macrophages

2020 ◽  
Vol 34 (11) ◽  
pp. 107708
Author(s):  
M.A. Valtierra-Alvarado ◽  
J.E. Castañeda Delgado ◽  
S.I. Ramírez-Talavera ◽  
G. Lugo-Villarino ◽  
F. Dueñas-Arteaga ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Metabolic Control ◽  
Human Monocytes

scholarly journals The effects of aerobic, resistance, and combined exercise on metabolic control, inflammatory markers, adipocytokines, and muscle insulin signaling in patients with type 2 diabetes mellitus

Metabolism ◽  
2011 ◽  
Vol 60 (9) ◽  
pp. 1244-1252 ◽  
Author(s):  
Maria Luiza Mendonça Pereira Jorge ◽  
Vanessa Neves de Oliveira ◽  
Nathalia Maria Resende ◽  
Lara Ferreira Paraiso ◽  
Antonio Calixto ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Metabolic Control ◽  
Insulin Signaling ◽  
Inflammatory Markers ◽  
Combined Exercise
Sign in / Sign up

Export Citation Format

Share Document